Email Alerts

Want to stay up to date on our news, events, and filings?

Set up your email alerts. Learn More

Press Releases

All Releases
View Summary Insmed to Present at the Leerink Swann Global Healthcare Conference
Feb 4, 2014
PDF 11.9 KB Add to Briefcase
View Summary Insmed Reports Third Quarter 2013 Financial Results
Nov 5, 2013
PDF 23.2 KB Add to Briefcase
View Summary Insmed Appoints David W.J. McGirr to Its Board of Directors
Nov 1, 2013
PDF 13.6 KB Add to Briefcase
View Summary Insmed to Host Third Quarter 2013 Financial Results Conference Call on Tuesday, November 5, 2013
Oct 23, 2013
PDF 12.5 KB Add to Briefcase
View Summary Insmed Completes Enrollment of Phase 2 Clinical Trial of ARIKACE to Treat Nontuberculous Mycobacteria Lung Disease in U.S. and Canada
Oct 15, 2013
PDF 17.9 KB Add to Briefcase
View Summary Insmed to Present at Leerink Swann Rare Disease Roundtable
Sep 25, 2013
PDF 11.0 KB Add to Briefcase
View Summary Insmed Fortifies Global Patent Portfolio
Sep 11, 2013
PDF 13.3 KB Add to Briefcase
View Summary Insmed to Participate in the Stifel Healthcare Conference 2013
Sep 4, 2013
PDF 11.3 KB Add to Briefcase
View Summary Insmed to Participate in August Investor Conferences
Aug 7, 2013
PDF 12.5 KB Add to Briefcase
View Summary Insmed Reports Second Quarter Financial Results
Aug 6, 2013
PDF 25.0 KB Add to Briefcase
View Summary Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013
Jul 31, 2013
PDF 12.5 KB Add to Briefcase
View Summary Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary
Jul 29, 2013
PDF 13.3 KB Add to Briefcase
View Summary Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
Jul 22, 2013
PDF 12.3 KB Add to Briefcase
View Summary Insmed Announces Pricing of Public Offering of Common Stock
Jul 17, 2013
PDF 12.8 KB Add to Briefcase
View Summary Insmed Announces Proposed Public Offering of Common Stock
Jul 15, 2013
PDF 12.5 KB Add to Briefcase
View Summary Insmed to Present at the 8th Annual JMP Securities Healthcare Conference
Jul 8, 2013
PDF 11.8 KB Add to Briefcase
View Summary ARIKACE Meets Primary Endpoint of Non-Inferiority to TOBI in Phase 3 Clinical Trial in Europe and Canada to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients
Jul 1, 2013
PDF 26.1 KB Add to Briefcase
View Summary Insmed to Report Top-Line Results From Phase 3 Clinical Trial of ARIKACE to Treat Pseudomonas Aeruginosa in Cystic Fibrosis
Jun 28, 2013
PDF 12.9 KB Add to Briefcase
View Summary Insmed to Join the Russell Global(R) and Russell 3000(R) Indexes
Jun 28, 2013
PDF 13.2 KB Add to Briefcase
View Summary Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe
May 14, 2013
PDF 13.0 KB Add to Briefcase
Showing 21-40 of 385 Page: 1 2 3 4 5 6 ... 20  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Prior Announcements

Key Clinical Publications

Insmed actively publishes and presents clinical data for ARIKAYCE.

Learn More

Email Alerts

Want to stay up to date on our news, events, and filings?

Set up your email alerts. Learn More

Investor & Media Contacts

Investor Relations
Anne Marie Fields
Senior Vice President
LHA
Phone: (212) 838-3777
E-mail

Bruce Voss
Managing Director
LHA
Phone: (310) 691-7100
E-mail

loading